Log In
BCIQ
Print this Print this
 

ISU303

  Manage Alerts
Collapse Summary General Information
Company Isu Abxis Co. Ltd.
DescriptionBiosimilar of fabrazyme
Molecular Target
Mechanism of ActionEnzyme replacement therapy; Biosimilar
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentPhase II
Standard IndicationFabry's disease
Indication DetailsTreat Fabry's disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today